Location History:
- Yamagata, JP (2008)
- Athens, GA (US) (2010)
Company Filing History:
Years Active: 2008-2010
Title: Innovations of Mika Kaneko
Introduction
Mika Kaneko is an accomplished inventor based in Athens, GA. He has made significant contributions to the field of biochemistry, particularly in the area of glycosyltransferases. With a total of 2 patents, his work has implications for various biological processes.
Latest Patents
Mika Kaneko's latest patents include the development of N-acetylglucosaminyltransferase Vb coding sequences, recombinant cells, and methods. This invention describes a previously unknown mammalian UDP-N-acetylglucosamine:α-6-D-mannoside β-1,6-N-acetylglucosaminyl-transferase, referred to as GlcNAc T-Vb. The patent details the coding sequence, protein, recombinant host cells, and antibodies that specifically bind to GlcNAc T-Vb. Notably, GlcNAc T-Vb is encoded on human chromosome 17, contrasting with the prior GlcNAc T-V, which is encoded on human chromosome 2.
Career Highlights
Mika Kaneko is affiliated with the University of Georgia Research Foundation, Inc., where he continues to advance his research. His work has garnered attention for its potential applications in medical and biotechnological fields.
Collaborations
Mika collaborates with notable colleagues, including James Michael Pierce and Maria Kamar, who contribute to his research endeavors.
Conclusion
Mika Kaneko's innovative work in the field of glycosyltransferases showcases his dedication to advancing scientific knowledge and technology. His contributions are poised to have a lasting impact on biochemistry and related disciplines.